Kenvue Vaping Cessation Study: Nicorette QuickMist Provides ‘Significant And Fast’ Relief

Use of Kenvue’s Nicorette QuickMist nicotine replacement therapy device resulted in “statistically significant reductions in urges to vape as soon as 30 seconds and up to two hours after dosing compared with placebo,” according to a recently published study funded by the firm.

• Source: Shutterstock

Use of Kenvue Inc.’s Nicorette QuickMist nicotine replacement therapy (NRT) device provides “statistically significant and fast relief” of urges to vape, according to a recently published study funded by the firm.

Published in the peer-reviewed journal

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from International

More from Geography